UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000018304 |
|---|---|
| Receipt number | R000021189 |
| Scientific Title | Randomized phase II study of two cross-over sequences, Gemcitabine/ docetaxel (A) and temozolomide/etoposide (B), for relapsed or refractory Osteosarcoma |
| Date of disclosure of the study information | 2015/07/15 |
| Last modified on | 2019/01/16 14:21:18 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2015/07/14 16:35:22 | ||
| 2 | Update | 2016/02/29 10:53:38 | Email1 |
|
| 3 | Update | 2016/02/29 10:54:52 | Recruitment status Anticipated trial start date |
|
| 4 | Update | 2018/01/15 07:41:29 | Name of primary person or sponsor Organization Category of Funding Organization |
|
| 5 | Update | 2018/07/17 07:56:05 | Recruitment status |
|
| 6 | Update | 2019/01/16 14:21:18 | Recruitment status |
